Honigman represented Elucid Bioimaging Inc. in the transaction, and Latham and Watkins represented Elevage Medical Technologies. Elucid Bioimaging Inc. announced it has raised $80 million in Series C...
Honigman represented Elucid Bioimaging Inc. in the transaction, and Latham and Watkins represented Elevage Medical Technologies. Elucid Bioimaging Inc. announced it has raised $80 million in Series C...
You must be a Standard 1 Year member to access this content.